@article{3077151,
    title = "Successful salvage of primary progressive Hodgkin lymphoma with the combination of post-transplant brentuximab vedotin and radiotherapy: Combining novelty and tradition",
    author = "Belia, M. and Chatzidimitriou, C. and Rondogianni, P. and Petsa, P. and Efstathopoulou, M. and Konstantinou, E. and Arapaki, M. and Asimakopoulos, J. and Plata, E. and Konstantopoulos, K. and Angelopoulou, M.K. and Vassilakopoulos, T.P.",
    journal = "Journal of Hematology & Oncology",
    year = "2021",
    volume = "39",
    number = "2",
    pages = "258-262",
    publisher = "John Wiley and Sons Ltd",
    issn = "1756-8722",
    doi = "10.1002/hon.2801",
    keywords = "bleomycin;  brentuximab vedotin;  busulfan;  cisplatin;  cytarabine;  dacarbazine;  doxorubicin;  etoposide;  gemcitabine;  ifosfamide;  melphalan;  steroid;  vinblastine;  vinorelbine tartrate;  brentuximab vedotin;  immunological antineoplastic agent, adult;  autologous stem cell transplantation;  cancer combination chemotherapy;  cancer radiotherapy;  cancer regression;  case report;  clinical article;  drug megadose;  drug withdrawal;  erythrocyte sedimentation rate;  human;  Letter;  lymphadenopathy;  male;  maximum standardized uptake value;  mediastinum mass;  minimal residual disease;  multiple cycle treatment;  nodular sclerosis Hodgkin lymphoma;  peripheral neuropathy;  positron emission tomography-computed tomography;  primary tumor;  priority journal;  salvage therapy;  treatment response;  autotransplantation;  female;  Hodgkin disease;  multimodality cancer therapy;  pathology;  procedures;  radiotherapy;  salvage therapy;  stem cell transplantation;  treatment outcome, Adult;  Antineoplastic Agents, Immunological;  Brentuximab Vedotin;  Combined Modality Therapy;  Female;  Hodgkin Disease;  Humans;  Male;  Radiotherapy;  Salvage Therapy;  Stem Cell Transplantation;  Transplantation, Autologous;  Treatment Outcome"
}